Silvia Bertagnolio

7.9k total citations · 4 hit papers
99 papers, 3.9k citations indexed

About

Silvia Bertagnolio is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Silvia Bertagnolio has authored 99 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Infectious Diseases, 60 papers in Virology and 25 papers in Epidemiology. Recurrent topics in Silvia Bertagnolio's work include HIV/AIDS Research and Interventions (72 papers), HIV/AIDS drug development and treatment (68 papers) and HIV Research and Treatment (60 papers). Silvia Bertagnolio is often cited by papers focused on HIV/AIDS Research and Interventions (72 papers), HIV/AIDS drug development and treatment (68 papers) and HIV Research and Treatment (60 papers). Silvia Bertagnolio collaborates with scholars based in Switzerland, United States and United Kingdom. Silvia Bertagnolio's co-authors include Michael R. Jordan, Diane Bennett, Donald Sutherland, Charles F. Gilks, Robert W. Shafer, James McMahon, Dana Clutter, Mark Myatt, Raph L Hamers and Tobias F. Rinke de Wit and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Silvia Bertagnolio

97 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The scope of the antimicrobial resistance challenge

2024 179 citations Silvia Bertagnolio et al. The Lancet profile →
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis

2022 131 citations Bradley J. Langford, Jean‐Paul Soucy et al. profile →
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

2023 91 citations Bradley J. Langford, Miranda So et al. The Lancet Microbe profile →
WHO global research priorities for antimicrobial resistance in human health

2024 68 citations Silvia Bertagnolio, Chad M. Centner et al. The Lancet Microbe profile →

Peers

Silvia Bertagnolio

VIROL

EPIDE

Raph L Hamers Netherlands

Frank van Leth Netherlands

Philippe Sudre Switzerland

Philippe Clevenbergh France

Sinata Koulla‐Shiro Cameroon

Sophie Matheron France

Eligius Lyamuya Tanzania

Ajay K. Sethi United States

Renaud Verdon France

Davis Mwakagile Tanzania

Raph L Hamers Netherlands

Silvia Bertagnolio

2.4k ×0.7

1.9k ×0.8

VIROL

585 ×0.6

EPIDE

135 ×0.4

131 ×0.5

Citations per year, relative to Silvia Bertagnolio Silvia Bertagnolio (= 1×) peers Raph L Hamers

Countries citing papers authored by Silvia Bertagnolio

Since Specialization

Citations

This map shows the geographic impact of Silvia Bertagnolio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Bertagnolio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Bertagnolio more than expected).

Fields of papers citing papers by Silvia Bertagnolio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Bertagnolio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Bertagnolio. The network helps show where Silvia Bertagnolio may publish in the future.

Co-authorship network of co-authors of Silvia Bertagnolio

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Bertagnolio. A scholar is included among the top collaborators of Silvia Bertagnolio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Bertagnolio. Silvia Bertagnolio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Centner, Chad M., et al.. (2025). Advancing equity in antimicrobial resistance research and policy. Trends in Microbiology. 34(1). 24–25.

Sliwa, Karen, Kavita Singh, Dimple Kondal, et al.. (2025). Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study. Global Heart. 20(1). 66–66. 2 indexed citations

Inzaule, Seth, Ronaldo Silva, Nathan Ford, et al.. (2025). Comparative analyses of COVID-19 in-hospital mortality in people with HIV during SARS-CoV-2 pre-Delta, Delta, and Omicron waves. AIDS. 39(14). 2114–2122. 1 indexed citations

Bastard, Mathieu, Dennis Falzon, Silvia Bertagnolio, et al.. (2024). Outcomes of people with TB reported to the WHO Global Clinical Platform of COVID-19. SHILAP Revista de lepidopterología. 1(8). 338–343. 1 indexed citations

Damen, Johanna AAG, Banafsheh Arshi, Maarten van Smeden, et al.. (2024). Validation of prognostic models predicting mortality or ICU admission in patients with COVID-19 in low- and middle-income countries: a global individual participant data meta-analysis. SHILAP Revista de lepidopterología. 8(1). 17–17. 2 indexed citations

Hamers, Raph L, Alessandro Cassini, Alice Tamara, et al.. (2023). Global knowledge gaps on antimicrobial resistance in the human health sector: A scoping review. International Journal of Infectious Diseases. 134. 142–149. 14 indexed citations

Langford, Bradley J., Miranda So, Valerie Leung, et al.. (2023). Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. The Lancet Microbe. 4(3). e179–e191. 91 indexed citations breakdown →

Hamers, Raph L, et al.. (2022). Developing a priority global research agenda for antimicrobial resistance in the human health sector: protocol for a scoping review. BMJ Open. 12(6). e060553–e060553. 5 indexed citations

Inzaule, Seth, Michael R. Jordan, George Bello, et al.. (2020). High levels of resistance to nucleoside/nucleotide reverse transcriptase inhibitors in newly diagnosed antiretroviral treatment-naive children in sub-Saharan Africa. AIDS. 34(10). 1567–1570. 7 indexed citations

10.

Clutter, Dana, Michael R. Jordan, Silvia Bertagnolio, & Robert W. Shafer. (2016). HIV-1 drug resistance and resistance testing. Infection Genetics and Evolution. 46. 292–307. 216 indexed citations

11.

Trotter, Andrew, et al.. (2014). Systematic review of HIV drug resistance in Southeast Asia.. PubMed. 15(3). 162–70. 14 indexed citations

12.

Shao, Wei, Irene Bontell, Fatim Cham, et al.. (2013). Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infection Genetics and Evolution. 18. 125–131. 37 indexed citations

13.

Parkin, Neil, Carmen de Mendoza, Rob Schuurman, et al.. (2012). Evaluation of In-house Genotyping Assay Performance Using Dried Blood Spot Specimens in the Global World Health Organization Laboratory Network. Clinical Infectious Diseases. 54(suppl 4). S273–S279. 21 indexed citations

14.

Gupta, Ravindra K., Michael R. Jordan, Binta Sultan, et al.. (2012). Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. The Lancet. 380(9849). 1250–1258. 270 indexed citations

15.

Hunt, Gillian, Johanna Ledwaba, Adriaan E. Basson, et al.. (2012). Surveillance of Transmitted HIV-1 Drug Resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009. Clinical Infectious Diseases. 54(suppl_4). S334–S338. 34 indexed citations

16.

Bertagnolio, Silvia, Martina Penazzato, Michael R. Jordan, et al.. (2012). World Health Organization Generic Protocol to Assess Drug-Resistant HIV Among Children <18 Months of Age and Newly Diagnosed With HIV in Resource-Limited Countries. Clinical Infectious Diseases. 54(suppl_4). S254–S260. 17 indexed citations

17.

Sultan, Binta, et al.. (2011). Prevalence of drug resistance in untreated HIV-1-infected individuals in low- and middle-income countries: a systematic review and meta-analysis. UCL Discovery (University College London). 1 indexed citations

18.

McMahon, James, Michael R. Jordan, Kent R. Kelley, et al.. (2011). Pharmacy Adherence Measures to Assess Adherence to Antiretroviral Therapy: Review of the Literature and Implications for Treatment Monitoring. Clinical Infectious Diseases. 52(4). 493–506. 119 indexed citations

19.

Tassie, Jean-Michel, Silvia Bertagnolio, & Yves Souteyrand. (2011). Integrated surveillance of HIV care in low-income and middle-income countries. Current Opinion in HIV and AIDS. 6(4). 233–238. 5 indexed citations

20.

Tumbarello, Mario, Evelina Tacconelli, Katleen de Gaetano Donati, et al.. (2001). Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome. European Respiratory Journal. 17(4). 636–640. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact